Jack Hugh Dean's most recent trade in Acurx Pharmaceuticals Inc was a trade of 9,852 Common Stock done at an average price of $1.0 . Disclosure was reported to the exchange on Jan. 6, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Acurx Pharmaceuticals Inc | Jack Hugh Dean | Director | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 06 Jan 2025 | 9,852 | 21,776 | - | 1.0 | 10,000 | Common Stock |
Acurx Pharmaceuticals Inc | Jack Hugh Dean | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 Jan 2025 | 9,852 | 9,852 | - | - | Warrants for Common Stock | |
Acurx Pharmaceuticals Inc | Jack Hugh Dean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 12,000 | 12,000 | - | - | Stock Option | |
Acurx Pharmaceuticals Inc | Jack Hugh Dean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option |